Download Files:
Products Details
Product Description
– eIF4A3-IN-7 is a potent inhibitor of eIF4A3. eIF4A3-IN-7 has the potential for researching cancer and other dysproliferative diseases (extracted from patent WO2019161345A1, Compound 8)[1].
Web ID
– HY-145361
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C26H25NO7
References
– [1]Yoshiyuki Fukase, et al. Agents and methods for treating dysproliferative diseases. Patent WO2019161345A1.
CAS Number
– 2374759-82-5
Molecular Weight
– 463.48
SMILES
– O[C@]12[C@](OC3=CC(OC)=CC(OC)=C32)(C4=CC=C(C=C4)O)[C@@](C5=CC=CC=C5)([H])[C@H]([C@H]1O)C(N)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Eukaryotic Initiation Factor (eIF)
Isoform
– eIF4
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
